EUVIMEDEUVIMED entdecken
Open Access

Celastrol inhibits gastric cancer cell proliferation, migration, and invasion via the FOXA1/CLDN4 axis

Wei Peng, Lin Chen, Jie Liu

Toxicology Research · 28.06.2023 · 12 (3) · 392-399

DOI: 10.1093/toxres/tfad024 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Toxicology Research, online erschienen am 20.04.2023. Verfasst von Wei Peng und 2 weiteren Autor:innen. Beteiligte Einrichtung: Changsha Social Work College, Changsha 410018, Hunan Province, China. Die Arbeit wurde bisher 42-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Scientific Research Program of Traditional Chinese Medicine of Hunan Province, Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Celastrol is a biologically active compound with potent anti-tumor properties. However, the mechanism of action of celastrol in gastric cancer (GC) has not been fully elucidated.

Methods

To explore the specific mechanism of the effect of celastrol on GC cells. GC cells were transfected with forkhead box A1 (FOXA1) or claudin 4 (CLDN4), or short hairpin RNA targeting FOXA1. The expressions of FOXA1 and CLDN4 in GC cells were determined by quantitative reverse transcription PCR and Western blot. GC cell proliferation, migration, and invasion were measured by MTT assay and Transwell assay, respectively. The interaction between CLDN4 and FOXA1 was examined by luciferase reporter assay. Resluts CLDN4 and FOXA1 were upregulated in GC cells. Celastrol prevented the proliferation, migration, and invasion of GC cells by downregulating FOXA1 expression. Overexpression of FOXA1 or CLDN4 accelerated GC progression. CLDN4 overexpression also induced the activation of the expressions of phosphoinositide 3-kinase (PI3K)/protein kinase B (AKT) pathway. FOXA1 enhanced the transcription of CLDN4.

Conclusion

Celastrol regulated GC progression via targeting the FOXA1/CLDN4 axis to impede the PI3K/AKT pathway. Our study proposed a new mechanism of how celastrol inhibited tumorigenesis in GC, which provided evidence for the potential use of celastrol for anti-GC treatment.

Schlagwörter

Stichwörter der Autor:innen

CLDN4FOXA1PI3K/AKT pathwaycelastrolgastric cancer

Autor:innen und Institutionen

  • Changsha Social Work College, Changsha 410018, Hunan Province, China.
  • Department of Internal Medicine, The First Affiliated Hospital of Changsha Medical College, Changsha 410219, Hunan Province, China.

Förderung

  • Scientific Research Program of Traditional Chinese Medicine of Hunan Province
  • Natural Science Foundation of China

Zitieren

APA

Peng, W., Chen, L., & Liu, J. (2023). Celastrol inhibits gastric cancer cell proliferation, migration, and invasion via the FOXA1/CLDN4 axis. Toxicology Research, 12(3), 392-399. https://doi.org/10.1093/toxres/tfad024

Vancouver

Peng W, Chen L, Liu J. Celastrol inhibits gastric cancer cell proliferation, migration, and invasion via the FOXA1/CLDN4 axis. Toxicology Research. 2023;12(3):392-399. doi:10.1093/toxres/tfad024

BibTeX
@article{Peng2023,
  author = {Peng, Wei and Chen, Lin and Liu, Jie},
  title = {Celastrol inhibits gastric cancer cell proliferation, migration, and invasion via the FOXA1/CLDN4 axis},
  journal = {Toxicology Research},
  year = {2023},
  volume = {12},
  number = {3},
  pages = {392--399},
  doi = {10.1093/toxres/tfad024}
}
Kostenlos starten →